Chloride Transfer During Continuous Renal Replacement Therapy in the Intensive Care Unit: a Prospective Observational Cohort Study

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

August 24, 2022

Study Completion Date

August 24, 2022

Conditions
Acute Kidney Injury
Interventions
DEVICE

Continuous veno-venous hemofiltration

Treatment of KDIGO stage 3 AKI by CVVH, in which renal replacement therapy is applied using a convection technique (ultrafiltration). Indication, choice of CRRT modality, and CRRT settings are made by the clinician in charge, following international recommendations. The measurement of chloride transfer over 24h is performed during CVVH treatment.

DEVICE

Continuous veno-venous hemodialysis

Treatment of KDIGO stage 3 AKI by CVVD, in which renal replacement therapy is applied using a diffusion technique (dialysis). Indication, choice of CRRT modality, and CRRT settings are made by the clinician in charge, following international recommendations. The measurement of chloride transfer over 24h is performed during CVVD treatment.

DEVICE

Continuous veno-venous hemodiafiltration

Treatment of KDIGO stage 3 AKI by CVVHDF, in which renal replacement therapy is applied using a combination of diffusion technique (dialysis) and convection technique (ultrafiltration). Indication, choice of CRRT modality, and CRRT settings are made by the clinician in charge, following international recommendations. The measurement of chloride transfer over 24h is performed during CVVHDF treatment.

Trial Locations (1)

69004

Hôpital de la Croix-Rousse (Hospices Civils de Lyon) / Médecine Intensive - Réanimation, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04755491 - Chloride Transfer During Continuous Renal Replacement Therapy in the Intensive Care Unit: a Prospective Observational Cohort Study | Biotech Hunter | Biotech Hunter